Merck & Co., Inc. (BIT:1MRKX)

Italy flag Italy · Delayed Price · Currency is EUR
99.90
+1.50 (1.52%)
At close: Feb 11, 2026
Market Cap244.33B +3.6%
Revenue (ttm)55.37B +1.3%
Net Income15.55B +6.6%
EPS6.20 +8.0%
Shares Outn/a
PE Ratio15.72
Forward PE22.73
Dividend2.16 (2.19%)
Ex-Dividend DateDec 12, 2025
Volume104
Average Volume275
Open98.70
Previous Close98.40
Day's Range97.80 - 99.70
52-Week Range65.40 - 104.40
Betan/a
RSI59.44
Earnings DateFeb 3, 2026

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, B... [Read more]

Industry Pharmaceutical Preparations
Founded 1891
Employees 75,000
Stock Exchange Borsa Italiana
Ticker Symbol 1MRKX
Full Company Profile

Financial Performance

In 2025, Merck & Co.'s revenue was $65.01 billion, an increase of 1.31% compared to the previous year's $64.17 billion. Earnings were $18.25 billion, an increase of 6.64%.

Financial numbers in USD Financial Statements